Gene and Cell Therapy Group
- Our research programme
- Contact Us
- Find Us
Thank you to the following organisations for sharing the day with us:
Retina Day was funded by a Wellcome Trust People Award
If you made a light catcher at Retina Day you can find out more about what happened to it as part of the Catching the Light project by clicking on the picture below.
Retina Day 2015 - Sat 10 Oct
etc.Venues St Paul's, 200 Aldersgate, London
Over 100 people joined us for Retina Day to meet with around 40 researchers and clinicians from the UCL Institute of Ophthalmology and Moorfields Eye Hospital - including people with inherited retinal conditions, families, friends, patient organisations and other healthcare professionals and researchers.
This free one-day event provided an opportunity to hear first-hand about the progress being made in world-leading research and in particular about developments into gene and stem cell interventions. Our agenda was shaped through discussions with people with inherited retinal disease to deliver a programme which covered the topics they most wanted to know about.
The day began with a series of short talks around where retinal research is today. Sue Drew of RP Fighting Blindness updated on the charity's research and patient support work, including an update on the RP Genome Project. Prof. James Bainbridge discussed what were some of the important developments and considerations for retinal disease research and Mr Saruban Pasu and Roy Smith talked about how patients are working with researchers to influence the design of research so it is more meaningful and beneficial. Prof. Michel Michaelides talked about the importance of continuing to study the progress of disease to help improve diagnosis, treatments and better understanding of long-term prognosis.
In the afternoon we heard from our research colleagues on the current status of gene and stem cell research for inherited retinal conditions. Dr Alexander Smith provided an update on progress in gene therapy including the recent findings of our clinical trial form RPE65 gene therapy for Leber Congenital Amaurosis Type 2. This was followed by Dr Tassos Georgiadis talking about some of the challenges of gene therapy and how new technologies like the CRISPR/Cas9 gene editing system may help us address some of these in the future. Dr Emma West followed, discussing the potential for stem cells not just in treating disease but also in helping to create new laboratory-based models of disease to improve our understanding of how new interventions might work in the human body.
We want to thank everyone who provided feedback on the day. We are so pleased to hear that people found the day both informative and enjoyable and we look forward to seeing you at future events which will be advertised on this website and on the website of the NIHR Moorfields Biomedical Research Centre.
You can click on any of the images or headings below to access content from the day.
|Background on IRDs||The Eye|
|Ask The Experts||Evaluation|
If you have any comments on this resource or on Retina Day you can let us know by contacting as at email@example.com.
Page last modified on 06 jul 16 10:14